Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NeonMind Biosciences Inc. (C:NEON)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for NEON within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jul 28, 2021 06:00 ET
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
VANCOUVER, BC / ACCESSWIRE / July 28, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today the appointment of Dr. Sagar Parikh, MD to its Specialty Clinics Advisory Board. In this role, Dr. Parikh will leverage his vast expertise in clinical treatment and int
Read full article
Jul 21, 2021 06:00 ET
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
VANCOUVER, BC / ACCESSWIRE / July 21, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTQBC:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today its R&D Working Group has completed an integrated drug development plan for its lead drug candidate targeting obesity, NEO-001, a high-dose psilocybin treatment cou
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
22.15
12.91
Price to Book - most recent quarter
6.64
4.27
3.58
Price to Cash Flow per share - TTM
--
13.80
18.29
Price to Free Cash Flow per share - TTM
--
14.22
29.01
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jul 15, 202127,359-50,244
Jun 30, 202177,60316,895
Jun 15, 202160,70814,366
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

NeonMind Biosciences Inc. is a psychedelic drug development company. The Company is engaged in developing and commercializing products that contain legal medicinal mushrooms and products that may contain psychedelic compounds. It engages in research into potentially therapeutic uses of compounds found in psychedelic mushrooms in treating weight loss, treating compulsive eating disorder, treating obesity or a complication of obesity, and/or altering the diet of an individual by administering psilocybin and/or other psychedelic compounds or their analogs or by administering psilocybin or its analog in conjunction with therapy or other treatments. The Company also offers a collection of four flavorful mushroom infused coffees, including two brewed versions and two instant versions. Its two instant mushroom coffee blends for on-the go is Rest Blend and Energize Blend. Its two traditional roasted mushroom coffee blends is Focus Blend (Dark Roast) and Protect Blend (Medium Roast).

See business summary

 

Twitter

Search (past week) for $NEON.CA

  • No tweets found